Skip to main content
TipRanks
Go Ultimate75% OFF

Jerry Malis Insider Profile

4 Followers

Jerry Malis, former EVP & Chief Scientific Officer at Synergetics USA, holds 344.20K shares in Synergetics USA (Ticker: ~SURG). Most recently, Jerry Malis Sold 10,000 shares of Synergetics USA on Oct 18, 2013 for an estimated value of $45.70K.

Jerry Malis's Trading History

~SURG
Synergetics USA
Oct 18, 2013―Informative Sell45.70K$2.30M
~SURG
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 18, 2013Informative Sell$45.70K10,000$4.57+23.20%
Oct 16, 2013Informative Sell$182.10K40,000$4.55+26.50%
Oct 10, 2013Informative Sell$232.90K50,605$4.60+31.10%
Oct 08, 2013Informative Sell$204.70K45,470$4.50+27.30%
Oct 08, 2013Informative Sell$17.51K3,925$4.46+27.30%

You May Also Like

Jerry Malis insider profile FAQ

What is the percentage of profitable transactions made by Jerry Malis?
The percentage of profitable transactions made by Jerry Malis is 100%.
What is the average return per transaction made by Jerry Malis?
The average return per transaction made by Jerry Malis is 38.60%.
What stocks does Jerry Malis hold?
Jerry Malis holds: ~SURG stocks.
What was Jerry Malis’s latest transaction?
Jerry Malis’s latest transaction was an Informative Sell of $45.70K.
What was Jerry Malis's most profitable transaction?
Jerry Malis’s most profitable transaction was an Informative Buy of ~SURG stock on October 19, 2010. The return on the trade was 124.20%.
What is Jerry Malis's role in Synergetics USA?
Jerry Malis's role in Synergetics USA is EVP & Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.